Evidence map›Paper›PMID 25587314›Full record

ArticleIranian journal of pharmaceutical research : IJPR2014

The Effect of Sumac (Rhus coriaria L.)Powder on Serum Glycemic Status, ApoB, ApoA-I and Total Antioxidant Capacity in Type 2 Diabetic Patients.

Farzad Shidfar, Seyedeh Tayebeh Rahideh, Asadollah Rajab, Nafise Khandozi, Sharieh Hosseini, Shahrzad Shidfar, Faraz Mojab

Open access · greenAbstract read
In one paragraph

Article in Iranian journal of pharmaceutical research : IJPR, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 4 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 4 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Effectiveness of sumac seedCaspian journal of internal medicine · 2025
    Article
  9. The Nutraceutical Properties ofInternational journal of molecular sciences · 2023
    Review
  10. Molecules (Basel, Switzerland) · 2022
    Review
  11. Article
  12. Pharmacological and Antioxidant Activities ofAntioxidants (Basel, Switzerland) · 2021
    Review
  13. Article
  14. Review
  15. Anti-Diabetic Effects ofIranian journal of pharmaceutical research : IJPR · 2018
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. The efficacy of sumac (Avicenna journal of phytomedicine
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Farzad ShidfarResearch Institute for Islamic and Complementary Medicine, Iran University of Medical Sciences, Tehran, Iran.
Seyedeh Tayebeh RahidehResearch Institute for Islamic and Complementary Medicine, Iran University of Medical Sciences, Tehran, Iran.
Asadollah RajabIranian Diabetes Association, Tehran, Iran.
Nafise KhandoziResearch Institute for Islamic and Complementary Medicine, Iran University of Medical Sciences, Tehran, Iran.
Sharieh HosseiniIslamic Azad University, Robat Karim Branch, Robat Karim, Iran.
Shahrzad ShidfarUniversity of Massachusetts, Worcester Memorial Hospital, Worcester, Massachusetts, USA.
Faraz MojabSchool of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Iran University of Medical Sciences · IRIranian Orthopedic Association · IRShahid Beheshti University of Medical Sciences · IRWorcester Memorial Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sumac (Rhus coriaria L.) is used as an herbal remedy in traditional medicine. The aim of this study was to determine the effects of sumac (R. coriaria) on serum glycemic status, apolipoprotein (apo) B, apoA-I and total antioxidant capacity (TAC) in type 2 diabetic patients. This double blind randomized controlled clinical trial was conducted on 41type 2 diabetic volunteers randomly assigned into 3g/day sumac powder (n=22) or placebo (n=19) groups over 3 months. Blood samples were collected before and after the intervention. Serum glucose and HbA1c were measured using enzymatic and turbidimetric inhibition immunoassay methods, respectively. ApoB, apoA-I and TAC were determined using turbidimetric immunoassay and spectrophotometric methods, respectively. There were significant decreases in serum glucose and HbA1c and also apoB levels at the end of study compared with initial values (P< 0.0001, P= 0.002 and P< 0.0001,respectively). Also, there was a significant difference in HbA1c and TAC levels between placebo and sumac groups at the end of study (P< 0.05).In sumac group, there were significant increase in apoA-I and TAC(P< 0.0001) compared with initial values. The mean of differences of serum glucose, HbA1c, apoB, apoA-I, apoB/apoA-I ratio and TAC between groups were significant (P< 0.05). In conclusion, these results showed the favorite effect of sumac consumption on serum glycemic status, apoB, apoA-I and TAC levels in in type 2 diabetic patients.

Indexed as

ApolipoproteinDiabetesGlycemic statusSumacTotal antioxidant capacity

Identifiers

PMID25587314
PMCPMC4232791
OpenAlexW2171093359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.